TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year
Subscribe To Our Newsletter & Stay Updated
